DiaMedica Therapeutics (DMAC)
(Delayed Data from NSDQ)
$3.31 USD
-0.14 (-4.06%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $3.39 +0.08 (2.42%) 6:56 PM ET
2-Buy of 5 2
D Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2024
Time: AMC |
6/2024 | $-0.16 | 0.00% |
Earnings Summary
For their last quarter, DiaMedica Therapeutics (DMAC) reported earnings of -$0.14 per share, beating the Zacks Consensus Estimate of $-0.16 per share. This reflects a positive earnings surprise of 12.50%. Look out for DMAC's next earnings release on August 07, 2024. For the next earning release, we expect the company to report earnings of -$0.16 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for DMAC
DiaMedica (DMAC) Up as Stroke Study Dosing Begins Post Relaunch
DMAC: What are Zacks experts saying now?
Zacks Private Portfolio Services